Lincoln Pharmaceuticals Limited is engaged in the business of manufacturing and trading pharmaceutical products, as well as undertaking contract manufacturing from pharmaceuticals companies across India and the globe. The Company’s product categories include tablets, capsules, liquid injection, cream in tubes, eye/ear drops, dry power injection, SVP injectables, dry-powder suspensions, liquid injection, and pharma products. It offers products for anti-infective, respiratory system, gynecology, cardio and CNS (central nervous system), antibacterial, dermatological infection, anti-diabetic, and anti-malaria. The Company is also engaged in building a portfolio of lifestyle and chronic segments, primarily in women’s healthcare and dermatology. The Company caters to approximately 60 countries in Europe, Latin America, Africa, Asia Pacific, Southeast Asia, and 26 states across India. The Company has two manufacturing facilities located in Mehsana and Khatraj, Gujarat.As of 25 May 2026, Lincoln Pharma share price is ₹719.15. The stock opened at ₹736.00, compared to its previous close of ₹734.15. During today's trading session, Lincoln Pharma share price moved in the range of ₹714.10 to ₹747.00, with an average price of ₹730.55 for the day. Looking at its last 52-week, the stock has touched a low of ₹714.10 and a high of ₹747.00. On the performance front, Lincoln Pharma share price has increased by 38.27% over the last six months and is up 28.73% on a year-on-year basis.
The market capitalization of Lincoln Pharma is ₹1,469 Crs, with a P/E ratio of 16.7 and a dividend yield of 0.25%.